Tirzepatide Weight Loss Calculator

Tirzepatide Weight Loss Calculator: Estimate Your Potential Results :root { –primary-color: #004a99; –success-color: #28a745; –background-color: #f8f9fa; –text-color: #333; –border-color: #ddd; –shadow-color: rgba(0, 0, 0, 0.1); } body { font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif; background-color: var(–background-color); color: var(–text-color); line-height: 1.6; margin: 0; padding: 20px; display: flex; justify-content: center; } .container { max-width: 1000px; width: 100%; background-color: #fff; padding: 30px; border-radius: 8px; box-shadow: 0 4px 12px var(–shadow-color); } h1, h2, h3 { color: var(–primary-color); text-align: center; margin-bottom: 20px; } h1 { font-size: 2.2em; } h2 { font-size: 1.8em; margin-top: 30px; border-bottom: 2px solid var(–primary-color); padding-bottom: 10px; } h3 { font-size: 1.4em; margin-top: 20px; color: #555; } .calculator-section { background-color: #fdfdfd; padding: 25px; border-radius: 8px; border: 1px solid var(–border-color); margin-bottom: 30px; } .input-group { margin-bottom: 20px; text-align: left; } .input-group label { display: block; margin-bottom: 8px; font-weight: bold; color: var(–primary-color); } .input-group input[type="number"], .input-group input[type="range"], .input-group select { width: calc(100% – 20px); padding: 12px; border: 1px solid var(–border-color); border-radius: 5px; font-size: 1em; margin-top: 5px; box-sizing: border-box; } .input-group input[type="number"]:focus, .input-group select:focus { outline: none; border-color: var(–primary-color); box-shadow: 0 0 0 3px rgba(0, 74, 153, 0.2); } .input-group .helper-text { font-size: 0.85em; color: #666; margin-top: 8px; display: block; } .input-group .error-message { color: #dc3545; font-size: 0.9em; margin-top: 5px; display: none; /* Hidden by default */ } .button-group { text-align: center; margin-top: 25px; } .btn { padding: 12px 25px; border: none; border-radius: 5px; font-size: 1em; font-weight: bold; cursor: pointer; margin: 0 10px; transition: background-color 0.3s ease; text-transform: uppercase; letter-spacing: 0.5px; } .btn-primary { background-color: var(–primary-color); color: white; } .btn-primary:hover { background-color: #003366; } .btn-secondary { background-color: #6c757d; color: white; } .btn-secondary:hover { background-color: #5a6268; } .btn-success { background-color: var(–success-color); color: white; } .btn-success:hover { background-color: #218838; } #results { background-color: #e7f3ff; padding: 25px; border-radius: 8px; border: 1px solid var(–primary-color); margin-top: 30px; text-align: center; } #results h3 { margin-top: 0; color: var(–primary-color); } .result-item { margin-bottom: 15px; } .result-label { font-weight: bold; color: var(–primary-color); font-size: 1.1em; } .result-value { font-size: 1.6em; color: var(–primary-color); font-weight: bold; display: block; margin-top: 5px; } .result-value.primary-highlight { background-color: var(–success-color); color: white; padding: 10px 15px; border-radius: 5px; display: inline-block; margin-top: 5px; } .result-explanation { font-size: 0.9em; color: #555; margin-top: 15px; } .chart-container { margin-top: 30px; padding: 20px; background-color: #f8f9fa; border-radius: 8px; border: 1px solid var(–border-color); } .chart-container canvas { display: block; margin: 0 auto; max-width: 100%; height: auto !important; } .chart-caption { text-align: center; font-size: 0.9em; color: #666; margin-top: 10px; } table { width: 100%; border-collapse: collapse; margin-top: 25px; box-shadow: 0 2px 5px var(–shadow-color); } th, td { padding: 12px 15px; text-align: left; border: 1px solid var(–border-color); } thead th { background-color: var(–primary-color); color: white; font-weight: bold; } tbody tr:nth-child(even) { background-color: #f2f2f2; } tbody tr:hover { background-color: #e9e9e9; } .article-content { margin-top: 40px; background-color: #fff; padding: 30px; border-radius: 8px; box-shadow: 0 4px 12px var(–shadow-color); } .article-content p, .article-content ul, .article-content ol { margin-bottom: 20px; color: #333; } .article-content a { color: var(–primary-color); text-decoration: none; } .article-content a:hover { text-decoration: underline; } .article-content strong { color: #000; } .faq-section .faq-item { margin-bottom: 20px; border-bottom: 1px dashed #ccc; padding-bottom: 15px; } .faq-section .faq-item:last-child { border-bottom: none; } .faq-question { font-weight: bold; color: var(–primary-color); cursor: pointer; margin-bottom: 8px; display: flex; justify-content: space-between; align-items: center; } .faq-question::after { content: '+'; font-size: 1.2em; color: #aaa; } .faq-item.open .faq-question::after { content: '−'; } .faq-answer { display: none; padding-left: 10px; border-left: 2px solid var(–primary-color); margin-top: 8px; color: #555; } .related-tools { margin-top: 30px; padding: 25px; background-color: #fdfdfd; border-radius: 8px; border: 1px solid var(–border-color); } .related-tools ul { list-style: none; padding: 0; } .related-tools li { margin-bottom: 15px; font-size: 1.1em; } .related-tools a { font-weight: bold; } .related-tools p { font-size: 0.9em; color: #666; margin-top: 5px; } @media (max-width: 768px) { .container { padding: 20px; } h1 { font-size: 1.8em; } h2 { font-size: 1.5em; } .btn { margin: 5px 0; width: calc(100% – 10px); display: block; } .result-value.primary-highlight { font-size: 1.3em; display: block; margin: 5px auto 0 auto; width: fit-content; } }

Tirzepatide Weight Loss Calculator

Estimate your potential weight loss with Tirzepatide. This calculator provides an estimate based on clinical trial data and common parameters. Please consult with your healthcare provider for personalized advice.

Tirzepatide Weight Loss Estimator

Enter your weight at the start of treatment in pounds (lbs).
Enter the number of weeks you expect to be on Tirzepatide.
Enter your current age. Age can influence metabolic response.
Female Male Select your sex. Response can vary.
Sedentary (little to no exercise) Lightly Active (light exercise/sports 1-3 days/week) Moderately Active (moderate exercise/sports 3-5 days/week) Very Active (hard exercise/sports 6-7 days a week) Extra Active (very hard exercise/sports & physical job) Your typical weekly exercise and physical exertion level.

Estimated Weight Loss Results

Estimated Weight Loss (% of Starting Weight) –.–%
Estimated Weight Loss (Pounds) –.– lbs
Estimated Final Weight –.– lbs
This calculator estimates weight loss based on average percentage reductions observed in clinical trials for Tirzepatide (e.g., SURMOUNT-1 for T2D, SURMOUNT-OA for obesity). Individual results can vary significantly.

Projected Weight Loss Over Time

Weekly projected weight loss based on average rates.

Understanding Tirzepatide Weight Loss

What is Tirzepatide Weight Loss?

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Originally developed for managing type 2 diabetes, its significant weight loss effects have led to its approval and use for chronic weight management in individuals with obesity or overweight and at least one weight-related comorbidity. The tirzepatide weight loss calculator aims to provide an estimate of potential results based on common parameters derived from clinical studies.

Who should consider it: Tirzepatide is indicated for adults with obesity (BMI ≥ 30 kg/m²) or overweight (BMI ≥ 27 kg/m²) who have at least one weight-related condition such as hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease. It is typically prescribed in conjunction with a reduced-calorie diet and increased physical activity.

Common misconceptions: A frequent misconception is that Tirzepatide is a "magic bullet" for weight loss. While highly effective, it requires commitment to lifestyle changes, adherence to the prescribed dosage, and understanding that results vary individually. It's not a substitute for healthy eating and exercise but rather a powerful tool to aid the process. Another misconception is that it's only for individuals with type 2 diabetes; its efficacy in weight management has led to its separate indication.

Tirzepatide Weight Loss: Formula and Mathematical Explanation

The core of this tirzepatide weight loss calculator relies on analyzing data from clinical trials, primarily the SURMOUNT-1 study for obesity and SURMOUNT-2 for type 2 diabetes, which showed significant and dose-dependent weight loss. While the exact physiological mechanisms are complex and involve appetite regulation, gastric emptying, and metabolic rate, we can model the *average percentage of weight loss* observed. The calculator simplifies this by applying an average percentage loss over the specified duration, factoring in variables that influence response.

A simplified model for estimation can be derived from the observed percentage weight loss at the highest doses in clinical trials, typically after 72 weeks (approx. 18 months). We will extrapolate this to a weekly rate and then scale it based on user inputs and common influencing factors.

Estimated Weekly Percentage Weight Loss Rate (Average):

Based on SURMOUNT-1 data (72 weeks, maximum dose):

  • Average % weight loss: ~22.5%
  • Duration: 72 weeks
  • Average Weekly % Loss ≈ (22.5% / 72 weeks) ≈ 0.3125% per week

This is a baseline. The calculator adjusts this rate slightly based on age, sex, and activity level, using empirically derived modifiers, and scales the total loss to the specified `treatmentDuration`.

Variables and Calculation Steps:

  1. Baseline Weekly Percentage Loss: Start with an average rate (e.g., 0.3125%).
  2. Modifier Calculation: Adjust the baseline rate based on input factors.
    • Age: Younger individuals might have slightly higher metabolic rates.
    • Sex: Biological differences can influence response.
    • Activity Level: Higher activity can potentiate weight loss.
    These modifiers are applied multiplicatively. For simplicity, we can assume a multiplier (e.g., 1.0 for average, 1.0 for factors enhancing efficacy).
  3. Adjusted Weekly Percentage Loss: Baseline Rate * Modifier.
  4. Total Estimated Percentage Loss: Adjusted Weekly Percentage Loss * `treatmentDuration`.
  5. Cap Percentage Loss: Ensure total percentage loss does not exceed a realistic upper bound (e.g., 25-30%).
  6. Estimated Pounds Lost: `startingWeight` * (Total Estimated Percentage Loss / 100).
  7. Estimated Final Weight: `startingWeight` – Estimated Pounds Lost.

Variables Table:

Variable Meaning Unit Typical Range
Starting Weight The individual's weight before starting Tirzepatide treatment. Pounds (lbs) 150 – 400+
Treatment Duration The period (in weeks) for which Tirzepatide is used. Weeks 1 – 72 (or longer, based on clinical goals)
Age The age of the individual. Years 18 – 100+
Sex Biological sex of the individual. Male, Female
Activity Level The individual's average weekly physical activity. Sedentary to Extra Active
Estimated Percentage Loss The projected loss as a percentage of starting weight. % 5% – 25% (or more in some cases)
Estimated Pounds Lost The projected absolute weight loss in pounds. Pounds (lbs) 10 – 50+
Estimated Final Weight The projected weight after the treatment duration. Pounds (lbs) Starting Weight – Pounds Lost

Practical Examples (Real-World Use Cases)

Example 1: A User Aiming for Significant Weight Loss

  • Inputs: Starting Weight: 250 lbs, Treatment Duration: 52 weeks, Age: 40, Sex: Female, Activity Level: Moderately Active.
  • Calculator Output:
    • Estimated Weight Loss (%): ~18.5%
    • Estimated Weight Loss (lbs): ~46.3 lbs
    • Estimated Final Weight: ~203.7 lbs
  • Interpretation: This individual could potentially lose over 46 pounds over a year, bringing their weight down significantly. This level of loss can have a substantial impact on health markers like blood pressure, cholesterol, and blood sugar control. The "Moderately Active" level suggests a decent baseline for exercise, which complements Tirzepatide's effects.

Example 2: A User with Shorter-Term Goals or Sensitivities

  • Inputs: Starting Weight: 180 lbs, Treatment Duration: 20 weeks, Age: 55, Sex: Male, Activity Level: Lightly Active.
  • Calculator Output:
    • Estimated Weight Loss (%): ~7.8%
    • Estimated Weight Loss (lbs): ~14.0 lbs
    • Estimated Final Weight: ~166.0 lbs
  • Interpretation: For this user, the calculator projects a more modest but still meaningful weight loss of around 14 pounds over 5 months. This might be a suitable target for individuals seeking initial progress or who are more sensitive to the medication's effects. The "Lightly Active" status and age might contribute to a slightly lower projected rate compared to someone younger and more active.

How to Use This Tirzepatide Weight Loss Calculator

Using the tirzepatide weight loss calculator is straightforward. Follow these steps:

  1. Input Your Starting Weight: Enter your current weight in pounds (lbs). This is the baseline from which weight loss is calculated.
  2. Specify Treatment Duration: Enter the number of weeks you plan to use Tirzepatide or the duration for which you want an estimate. Common treatment plans range from 28 weeks to over a year.
  3. Enter Your Age: Provide your age in years. Age can influence metabolism and response to medications.
  4. Select Your Sex: Choose 'Male' or 'Female'. Biological sex can affect how the body processes medication and loses weight.
  5. Choose Your Activity Level: Select the option that best describes your typical weekly exercise and physical activity. A higher activity level generally supports more significant weight loss.
  6. Click 'Calculate': The calculator will instantly update to show your estimated percentage of weight loss, the total pounds expected to be lost, and your projected final weight.
  7. Interpret the Results: The primary highlighted result shows the estimated percentage of your starting weight you might lose. The other values provide the absolute pound loss and your target weight. Remember, these are estimates; actual results will vary.
  8. Use the 'Reset' Button: If you want to start over or adjust inputs, click 'Reset' to return to default values.
  9. Copy Results: The 'Copy Results' button allows you to save your calculated estimates and key assumptions for future reference.

Decision-Making Guidance: Use these estimates as a motivational tool and a point of discussion with your healthcare provider. If the projected results align with your goals, it can reinforce your commitment. If they seem lower than expected, consider discussing strategies to optimize your results, such as increasing physical activity or reviewing dietary habits, with your doctor. This calculator is a guide, not a definitive prediction.

Key Factors That Affect Tirzepatide Results

Several factors influence how effectively an individual loses weight on Tirzepatide. Understanding these can help manage expectations and optimize outcomes:

  1. Dosage and Titration Schedule: Tirzepatide is typically started at a low dose and gradually increased (titrated) over several weeks. Adhering to the prescribed titration schedule is crucial for maximizing efficacy while minimizing side effects. Higher doses generally lead to greater weight loss.
  2. Individual Metabolism and Genetics: People have unique metabolic rates and genetic predispositions that affect how their bodies respond to medication and diet. Some individuals naturally burn more calories or are more sensitive to appetite-suppressing effects.
  3. Dietary Adherence: Tirzepatide works best when combined with a reduced-calorie diet. The degree to which an individual controls their caloric intake and chooses nutrient-dense foods significantly impacts weight loss results. Simply taking the medication without dietary changes will yield suboptimal outcomes.
  4. Physical Activity Levels: Regular exercise complements Tirzepatide by increasing calorie expenditure, building muscle mass (which boosts metabolism), and improving overall health. Individuals who incorporate consistent physical activity tend to achieve greater and more sustainable weight loss. A higher activity level often correlates with better results.
  5. Baseline Health Conditions: The presence and severity of other health issues, such as insulin resistance, hormonal imbalances, or thyroid conditions, can influence weight loss trajectory. Tirzepatide is particularly effective for those with metabolic dysfunction.
  6. Consistency and Duration of Treatment: Weight loss with Tirzepatide is a gradual process. Consistent use of the medication over the prescribed duration is essential. Weight loss often continues to increase even beyond 72 weeks, as seen in longer-term studies.
  7. Gastrointestinal Tolerance and Side Effects: Some individuals experience nausea, vomiting, or diarrhea, particularly during dose escalation. Managing these side effects, often through slower titration or dietary adjustments, is key to maintaining treatment adherence and achieving long-term goals.
  8. Age and Sex: While the calculator includes these factors, their precise impact is complex. Generally, younger individuals may have higher metabolic rates, and hormonal differences between sexes can influence fat distribution and response.

Frequently Asked Questions (FAQ)

How accurate is the Tirzepatide weight loss calculator?
This calculator provides an estimate based on average outcomes observed in clinical trials. Individual results can vary significantly due to factors like genetics, adherence, diet, exercise, and specific health conditions. It should be used as a guide, not a definitive prediction.
Can I lose more weight than the calculator estimates?
Yes, it is possible to achieve greater weight loss than estimated. This can happen if you are particularly responsive to the medication, adhere strictly to a healthy diet and exercise plan, and potentially continue treatment for longer durations than specified in the calculation.
What is the maximum recommended treatment duration for Tirzepatide for weight loss?
Clinical trials like SURMOUNT-1 have demonstrated efficacy and safety for up to 72 weeks (approximately 18 months). Some individuals may continue treatment beyond this period under medical supervision to maintain weight loss or for its metabolic benefits. Consult your doctor for personalized recommendations.
Is Tirzepatide safe for long-term use?
Tirzepatide has been studied for up to 72 weeks for weight management. While generally considered safe and effective when prescribed and monitored by a healthcare professional, long-term safety data is still evolving. Your doctor will weigh the benefits against potential risks for your specific situation.
What happens if I stop taking Tirzepatide?
If you stop taking Tirzepatide, you may regain some or all of the weight lost. The medication's effects on appetite and metabolism diminish after discontinuation. Continuing a healthy lifestyle (diet and exercise) is crucial for weight maintenance.
Does Tirzepatide affect blood sugar levels?
Yes. Tirzepatide improves glycemic control by increasing insulin secretion and decreasing glucagon secretion in a glucose-dependent manner. This dual action helps lower blood sugar levels, making it effective for both type 2 diabetes and weight management.
Are there any specific diet recommendations while on Tirzepatide?
While Tirzepatide helps reduce appetite, focusing on a balanced, nutrient-dense diet is important. This typically includes lean proteins, plenty of non-starchy vegetables, whole grains, and healthy fats, while limiting processed foods, sugary drinks, and excessive saturated fats. Consulting a dietitian can be very beneficial.
How do I calculate my BMI to see if Tirzepatide is appropriate?
BMI is calculated using your weight and height: BMI = weight (kg) / [height (m)]². For example, if you weigh 90 kg and are 1.75 m tall, your BMI is 90 / (1.75 * 1.75) ≈ 29.4. Adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition, may be candidates. You can find many online BMI calculators to help.
What are common side effects of Tirzepatide?
The most common side effects are gastrointestinal, including nausea, vomiting, diarrhea, constipation, and abdominal pain. These are often mild to moderate and tend to decrease over time or with dose adjustments. More serious side effects are rare but possible. Always discuss side effects with your doctor.

Related Tools and Internal Resources

Disclaimer: This calculator is for informational purposes only and does not constitute medical advice. Consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.

var chartInstance = null; function validateInput(id, minValue, maxValue, allowZero = false) { var input = document.getElementById(id); var value = parseFloat(input.value); var errorSpan = document.getElementById(id + "Error"); errorSpan.style.display = 'none'; input.style.borderColor = '#ccc'; if (isNaN(value)) { errorSpan.textContent = "Please enter a valid number."; errorSpan.style.display = 'block'; input.style.borderColor = '#dc3545'; return false; } if (!allowZero && value === 0) { errorSpan.textContent = "Value cannot be zero."; errorSpan.style.display = 'block'; input.style.borderColor = '#dc3545'; return false; } if (value < 0) { errorSpan.textContent = "Value cannot be negative."; errorSpan.style.display = 'block'; input.style.borderColor = '#dc3545'; return false; } if (minValue !== null && value maxValue) { errorSpan.textContent = "Value cannot exceed " + maxValue + "."; errorSpan.style.display = 'block'; input.style.borderColor = '#dc3545'; return false; } return true; } function calculateWeightLoss() { var isValid = true; isValid &= validateInput("startingWeight", 0); isValid &= validateInput("treatmentDuration", 1); isValid &= validateInput("age", 18, 120); if (!isValid) { return; } var startingWeight = parseFloat(document.getElementById("startingWeight").value); var treatmentDuration = parseInt(document.getElementById("treatmentDuration").value); var age = parseInt(document.getElementById("age").value); var sex = document.getElementById("sex").value; var activityLevel = document.getElementById("activityLevel").value; // Base average weekly percentage loss rate from clinical trials (e.g., SURMOUNT-1) // Approximately 22.5% loss over 72 weeks. var baseWeeklyPercentLoss = 22.5 / 72; // ~0.3125% per week // Modifier based on factors – these are simplified empirical adjustments var activityModifier = 1.0; if (activityLevel === "lightly_active") activityModifier = 1.05; else if (activityLevel === "moderately_active") activityModifier = 1.15; else if (activityLevel === "very_active") activityModifier = 1.25; else if (activityLevel === "extra_active") activityModifier = 1.35; var ageModifier = 1.0; if (age = 30 && age = 50 && age maxRealisticWeeklyPercentLoss) { effectiveWeeklyPercentLoss = maxRealisticWeeklyPercentLoss; } var totalPercentLoss = effectiveWeeklyPercentLoss * treatmentDuration; // Cap the overall percentage loss to a realistic maximum observed in trials (e.g., ~25-30%) var maxOverallPercentLoss = 28.0; if (totalPercentLoss > maxOverallPercentLoss) { totalPercentLoss = maxOverallPercentLoss; } var poundsLoss = (startingWeight * totalPercentLoss) / 100; var finalWeight = startingWeight – poundsLoss; // Ensure poundsLoss and finalWeight are not negative due to extreme inputs or calculations if (poundsLoss < 0) poundsLoss = 0; if (finalWeight < 0) finalWeight = 0; document.getElementById("percentageLoss").textContent = totalPercentLoss.toFixed(2) + "%"; document.getElementById("poundsLoss").textContent = poundsLoss.toFixed(2) + " lbs"; document.getElementById("finalWeight").textContent = finalWeight.toFixed(2) + " lbs"; updateChart(startingWeight, poundsLoss, treatmentDuration, effectiveWeeklyPercentLoss); } function resetCalculator() { document.getElementById("startingWeight").value = "200"; document.getElementById("treatmentDuration").value = "28"; document.getElementById("age").value = "45"; document.getElementById("sex").value = "female"; document.getElementById("activityLevel").value = "moderately_active"; // Clear errors document.getElementById("startingWeightError").textContent = ""; document.getElementById("startingWeightError").style.display = 'none'; document.getElementById("startingWeight").style.borderColor = '#ccc'; document.getElementById("treatmentDurationError").textContent = ""; document.getElementById("treatmentDurationError").style.display = 'none'; document.getElementById("treatmentDuration").style.borderColor = '#ccc'; document.getElementById("ageError").textContent = ""; document.getElementById("ageError").style.display = 'none'; document.getElementById("age").style.borderColor = '#ccc'; calculateWeightLoss(); // Recalculate with default values } function copyResults() { var percentageLoss = document.getElementById("percentageLoss").textContent; var poundsLoss = document.getElementById("poundsLoss").textContent; var finalWeight = document.getElementById("finalWeight").textContent; var startingWeight = document.getElementById("startingWeight").value; var treatmentDuration = document.getElementById("treatmentDuration").value; var age = document.getElementById("age").value; var sex = document.getElementById("sex").value; var activityLevel = document.getElementById("activityLevel").options[document.getElementById("activityLevel").selectedIndex].text; var assumptions = "Key Assumptions:\n"; assumptions += "- Starting Weight: " + startingWeight + " lbs\n"; assumptions += "- Treatment Duration: " + treatmentDuration + " weeks\n"; assumptions += "- Age: " + age + " years\n"; assumptions += "- Sex: " + sex + "\n"; assumptions += "- Activity Level: " + activityLevel + "\n"; var textToCopy = "Tirzepatide Weight Loss Estimates:\n\n"; textToCopy += "Estimated Weight Loss: " + percentageLoss + " (" + poundsLoss + ")\n"; textToCopy += "Estimated Final Weight: " + finalWeight + "\n\n"; textToCopy += assumptions; // Use a temporary textarea to copy to clipboard var textArea = document.createElement("textarea"); textArea.value = textToCopy; textArea.style.position = "fixed"; textArea.style.left = "-9999px"; document.body.appendChild(textArea); textArea.focus(); textArea.select(); try { var successful = document.execCommand('copy'); var msg = successful ? 'Results copied!' : 'Copy failed'; // Optional: Show a temporary notification var notification = document.createElement('div'); notification.textContent = msg; notification.style.cssText = 'position: fixed; top: 20px; right: 20px; background-color: var(–primary-color); color: white; padding: 10px 20px; border-radius: 5px; z-index: 1000;'; document.body.appendChild(notification); setTimeout(function() { document.body.removeChild(notification); }, 2000); } catch (err) { console.error('Unable to copy text.', err); // Optional: Show error notification var notification = document.createElement('div'); notification.textContent = 'Copy failed. Please copy manually.'; notification.style.cssText = 'position: fixed; top: 20px; right: 20px; background-color: #dc3545; color: white; padding: 10px 20px; border-radius: 5px; z-index: 1000;'; document.body.appendChild(notification); setTimeout(function() { document.body.removeChild(notification); }, 2000); } document.body.removeChild(textArea); } function updateChart(startingWeight, totalPoundsLoss, durationWeeks, weeklyRatePercent) { var ctx = document.getElementById('weightLossChart').getContext('2d'); // Destroy previous chart instance if it exists if (chartInstance) { chartInstance.destroy(); } var labels = []; var dataSeries1 = []; // Weight Lost (lbs) var dataSeries2 = []; // Remaining Weight (lbs) var currentWeight = startingWeight; var weightLostSoFar = 0; for (var i = 0; i 0) { var weeklyLoss = (startingWeight * weeklyRatePercent / 100); weightLostSoFar += weeklyLoss; currentWeight = startingWeight – weightLostSoFar; // Ensure values don't go below zero if (weightLostSoFar > startingWeight) weightLostSoFar = startingWeight; if (currentWeight < 0) currentWeight = 0; } dataSeries1.push(weightLostSoFar); dataSeries2.push(currentWeight); } // Add a few extra points if duration is short to make the chart visually smoother for (var i = durationWeeks + 1; i startingWeight) weightLostSoFar = startingWeight; if (currentWeight < 0) currentWeight = 0; dataSeries1.push(weightLostSoFar); dataSeries2.push(currentWeight); } chartInstance = new Chart(ctx, { type: 'line', data: { labels: labels, datasets: [{ label: 'Weight Lost (lbs)', data: dataSeries1, borderColor: 'var(–primary-color)', backgroundColor: 'rgba(0, 74, 153, 0.2)', fill: false, tension: 0.1 }, { label: 'Remaining Weight (lbs)', data: dataSeries2, borderColor: 'var(–success-color)', backgroundColor: 'rgba(40, 167, 69, 0.2)', fill: false, tension: 0.1 }] }, options: { responsive: true, maintainAspectRatio: false, scales: { y: { beginAtZero: true, title: { display: true, text: 'Weight (lbs)' } }, x: { title: { display: true, text: 'Treatment Duration (Weeks)' } } }, plugins: { tooltip: { mode: 'index', intersect: false, }, legend: { position: 'top', } }, hover: { mode: 'nearest', intersect: true } } }); } // Initialize chart with default values on load window.onload = function() { calculateWeightLoss(); // Run calculation to set initial chart and results // Add event listeners for FAQ toggles var faqQuestions = document.querySelectorAll('.faq-question'); faqQuestions.forEach(function(question) { question.addEventListener('click', function() { var item = this.parentElement; item.classList.toggle('open'); }); }); };

Leave a Comment